Risk of cervical cancer in women with a family history of breast and female genital tract neoplasms

International Journal of Cancer

Volumn 117, Issue 5, 2005, Pages 880-881

  Negri, Eva ^a   La Vecchia, Carlo ^a,b   Bosetti, Cristina ^a   Franceschi, Silvia ^c   Parazzini, Fabio ^a,b  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; ENDOMETRIUM CANCER; FAMILY HISTORY; FEMALE; GYNECOLOGIC CANCER; HUMAN; LETTER; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; SWEDEN; UTERINE CERVIX CANCER; UTERUS CANCER;

ADOLESCENT; ADULT; AGED; BREAST NEOPLASMS; CONFIDENCE INTERVALS; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; MIDDLE AGED; ODDS RATIO; RISK FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 27744474124     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.21211     Document Type: Letter

References (14)

1. Zelmanowicz A, Schiffman M, Herrero R, Goldstein AM, Sherman ME, Burk RD, Gravitt P, Viscid R, Schwartz P, Barnes W, Mortel R, Silverberg SG, et al. Family history as a co-factor for adenocarcinoma and squamous cell carcinoma of the uterine cervix: results from two studies conducted in Costa Rica and the United States. Int J Cancer, in press.
2. Hemminki K, Dong C, Vaittinen P. Familial risks in cervical cancer, is there a hereditary component? Int J Cancer 1999;82:775-81.
3. Hemminki K, Li X, Mutanen P. Familial risks in invasive and in situ cervical cancer by histological type. Eur J Cancer Prev 2001;10:83-9.
4. Parazzini F, Chatenoud L, La Vecchia C, Chiaffarino F, Ricci E, Negri E. Time since last use of oral contraceptives and risk of invasive cervical cancer. Eur J Cancer 1998;34:884-8.
5. Chiaffarino F, Gallus S, Negri E, Parazzini F, Franceschi S, La Vecchia C. Correspondence re: Weiderpass et al., Alcoholism and risk of cervix uteri, vagina, and vulva (Cancer Epidemiol Biomark Prev 10: 899-901, 2001). Cancer Epidemiol Biomarkers Prev 2002;11:325-6.
6. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J, eds. Cancer incidence in five continents, vol. VII. IARC Scientific Publications no. 143. Lyon: IARC, 1997.
7. Breslow NE, Day NE. Statistical methods in cancer research, vol. 1. The analysis of case-control studies. IARC Scientific Publications no. 32. Lyon: IARC, 1980.
8. Theis B, Boyd N, Lockwood G, Tritchler D. Accuracy of family cancer history in breast cancer patients. Eur J Cancer Prev 1994;3:321-7.
9. Paganini-Hill A, Ross RK. Reliability of recall of drug usage and other health-related information. Am J Epidemiol 1982;116:114-22.
10. Bosch FX, de Sanjosé S. Human Papillomavirus and cervical cancer-burden and assessment of causality. J Natl Cancer Inst Monogr 2003;31:3-13.
11. Berrington de Gonzales A, Sweetland S, Green J. Comparison of risk factors for squamous cell and adenocarcinomas of the cervix: a meta-analysis. Br J Cancer 2004;90:1787-91.
12. Parazzini F, La Vecchia C. Epidemiology of adenocarcinoma of the cervix. Gynecol Oncol 1990;39:40-6.
13. Kjaer SK, Brinton LA. Adenocarcinomas of the uterine cervix: the epidemiology of an increasing problem. Epidemiol Rev 1993;15:486-98.
14. Hemminki K, Li X. Familial risk of cancer by site and histopathology. Int J Cancer 2003;103:105-9.